Renalytix Plc
RNLXY
$0.225
$0.00853.93%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -4.73M | -7.07M | -7.74M | -8.49M | -10.15M |
| Total Depreciation and Amortization | 60.00K | -40.00K | 69.00K | 108.00K | 127.00K |
| Total Amortization of Deferred Charges | -- | 100.00K | -- | -- | -- |
| Total Other Non-Cash Items | 918.00K | 2.02M | 2.08M | 470.00K | 1.94M |
| Change in Net Operating Assets | -86.00K | -2.83M | 734.00K | -12.00K | -1.42M |
| Cash from Operations | -3.84M | -7.83M | -4.86M | -7.92M | -9.50M |
| Capital Expenditure | -- | -1.00K | -3.00K | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -1.00K | -3.00K | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 0.00 | 0.00 | -600.00K | -1.06M |
| Issuance of Common Stock | 23.00K | 8.46M | 5.07M | 93.00K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -672.00K | -1.04M | 0.00 | -5.00K |
| Cash from Financing | 23.00K | 7.79M | 4.03M | -507.00K | -1.07M |
| Foreign Exchange rate Adjustments | 42.00K | 14.00K | -83.00K | 154.00K | -222.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.77M | -24.00K | -915.00K | -8.27M | -10.79M |
